524661 — Welcure Drugs and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹222.47m
- IN₹216.71m
- IN₹3.66bn
Annual balance sheet for Welcure Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Preliminary |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.66 | 0.012 | 0.216 | 196 | 5.76 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 0.002 | 0 | 190 | 2,134 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.66 | 0.059 | 0.318 | 1,821 | 3,575 |
| Net Property, Plant And Equipment | — | 0.568 | 0.209 | 0.303 | 0.111 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.968 | 15.3 | 13.7 | 2,670 | 5,102 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.038 | 0.136 | 0.306 | 413 | 4,132 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.038 | 0.136 | 0.306 | 1,645 | 4,132 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 0.93 | 15.2 | 13.4 | 1,025 | 970 |
| Total Liabilities & Shareholders' Equity | 0.968 | 15.3 | 13.7 | 2,670 | 5,102 |
| Total Common Shares Outstanding |